Recursion Pharmaceuticals RXRX Institutional Ownership

NASDAQ RXRX

$3.64 -0.02 (-0.55%)

At close: Oct 21, 2026 · 4:00 PM EDT

As of the 13F quarter ended Jun 30, 2026, 344 institutions held 67.96% of Recursion Pharmaceuticals (RXRX) shares outstanding. Versus the prior quarter, institutional ownership was up 4.51 percentage points, the holder count rose by 10 and shares held were up 7.65%. The largest holder is BlackRock, Inc. with 50.30Mn shares (9.45% of outstanding).

Updated Oct 11, 2026 Recursion Pharmaceuticals (RXRX) stock price and overview

Institutions by Trading Activity

344 Institutions

Increased 180 52.3%

Unchanged 62 18.0%

Reduced 102 29.7%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

67.96%

▲+4.51 pp QoQ

Shares Held by Institutions

361.86Mn

of 532.46Mn outstanding

▲+7.65% QoQ

Shares Outstanding

532.46Mn

170.60Mn held outside 13F filers

Institutional Investors

344

filed 13F for Jun 2026

▲+10 vs prior quarter

Net Shares Added (QoQ)

+25.72Mn

accumulated since last quarter

Value of Holdings

$1.32Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 11, 2026

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) was held by 343 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

These investors held 67.96% of Recursion Pharmaceuticals' outstanding shares at the end of Q2 2026, up from 63.45% in Q1 2026.
Total shares held in Recursion Pharmaceuticals rose 7.65% from Q1 2026, while the number of holders rose 5.21% from Q2 2025.
Looking at the 343 holders of RXRX individually, 179 added to their positions, 102 reduced their stakes and 62 left their positions unchanged.
In total, institutional investors held 361.84Mn shares of Recursion Pharmaceuticals at the end of Q2 2026, up 25.7Mn from the prior quarter and up 59.37Mn from a year earlier.
As of June 30, 2026, the biggest holder of Recursion Pharmaceuticals was BlackRock, Inc. with 50.3Mn shares, or 9.45% of shares outstanding.
The largest position increases in RXRX for Q2 2026 were by Vanguard Portfolio Management LLC (+8.37Mn shares), BlackRock, Inc. (+7.11Mn shares), State Street Corp (+6.22Mn shares), UBS Group AG (+3.85Mn shares) and Marshall Wace, LLP (+1.84Mn shares).
Holders that trimmed the most shares of Recursion Pharmaceuticals in Q2 2026 while keeping a position were Lingotto Investment Management LLP (-3.68Mn shares), UBS Asset Management Americas (-3.26Mn shares), Goldman Sachs Group Inc (-2.15Mn shares), Susquehanna International Group, LLP (-933.15K shares) and Millennium Management LLC (-777.51K shares).
Per Business Quant, the top 10 investors in RXRX for the quarter ended June 30, 2026 were BlackRock, Inc. (50.3Mn shares), ARK Investment Management LLC (41.34Mn shares), State Street Corp (34.71Mn shares), Vanguard Portfolio Management LLC (31.13Mn shares), Baillie Gifford & Co (23.49Mn shares), Vanguard Capital Management LLC (22.77Mn shares), Geode Capital Management, LLC (13.82Mn shares), Softbank Group Corp. (13.64Mn shares), MIC Capital Management UK LLP (9.64Mn shares) and UBS Group AG (8.95Mn shares).

Form 13F Holdings

344 Institutional Holders

Report period 30 Jun, 2026

Total shares held 361.86Mn

Of outstanding 67.96%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	BlackRock, Inc.	0002012383	50,304,691	9.45%	▲7,112,385	+16.47%	$184.62Mn
2	ARK Investment Management LLC	0001697748	41,337,632	7.76%	▲1,124,863	+2.80%	$151.71Mn
3	State Street Corp	0000093751	34,706,130	6.52%	▲6,215,492	+21.82%	$127.37Mn
4	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	31,131,599	5.85%	▲8,372,499	+36.79%	$114.25Mn
5	BAILLIE GIFFORD & CO	0001088875	23,487,907	4.41%	▼187,500	-0.79%	$86.20Mn
6	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	22,765,940	4.28%	▲521,553	+2.34%	$83.55Mn
7	GEODE CAPITAL MANAGEMENT, LLC	0001214717	13,819,135	2.60%	▲1,544,051	+12.58%	$50.72Mn
8	Softbank Group Corp.	0001065521	13,636,515	2.56%	0	0.00%	$50.05Mn
9	MIC Capital Management UK LLP	0001889830	9,644,033	1.81%	▲1	+0.00%	$35.39Mn
10	UBS Group AG	0001610520	8,947,102	1.68%	▲3,845,865	+75.39%	$32.84Mn
11	NORGES BANK	0001374170	6,833,534	1.28%	▲6,833,534	0.00%	$25.08Mn
12	Data Collective IV GP, LLC	0001664974	5,941,120	1.12%	0	0.00%	$21.80Mn
13	Amova Asset Management Americas, Inc.	0001480751	5,511,687	1.04%	▲92,466	+1.71%	$20.23Mn
13	Sumitomo Mitsui Trust Group, Inc.	0001475365	5,511,687	1.04%	▲92,466	+1.71%	$20.23Mn
14	Northern Trust Corp	0000073124	4,758,236	0.89%	▲789,825	+19.90%	$17.46Mn
15	MARSHALL WACE, LLP	0001318757	4,714,577	0.89%	▲1,837,649	+63.88%	$17.30Mn
16	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0000884546	4,138,286	0.78%	▲329,488	+8.65%	$15.19Mn
17	DCVC Opportunity Fund II GP, LLC	0001668343	3,951,141	0.74%	0	0.00%	$14.50Mn
18	Goldman Sachs Group Inc	0000886982	3,917,858	0.74%	▼2,147,803	-35.41%	$14.38Mn
19	VANGUARD FIDUCIARY TRUST CO	0000933478	3,470,558	0.65%	▼44,425	-1.26%	$12.74Mn

Showing 1 to 20 of 344 holders